Cargando…
Editorial: Differentiated Thyroid Cancer - Risk Adapted Therapy, Genetic Profiling and Clinical Staging
Autores principales: | Reiners, Christoph, Drozd, Valentina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531744/ https://www.ncbi.nlm.nih.gov/pubmed/34690935 http://dx.doi.org/10.3389/fendo.2021.755323 |
Ejemplares similares
-
Editorial: Radiation as Risk Factor, Early Diagnosis, Therapy, and Follow-up of Differentiated Thyroid Cancer
por: Reiners, Christoph, et al.
Publicado: (2021) -
Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such Patients
por: Drozd, Valentina, et al.
Publicado: (2020) -
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey
por: Reiners, Christoph, et al.
Publicado: (2020) -
Editorial: The role of genetic alterations in thyroid carcinoma
por: Feldkamp, Joachim
Publicado: (2022) -
A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis
por: Drozd, Valentina, et al.
Publicado: (2021)